Income Statement Huntsman Corporation

Equities

HUN

US4470111075

Diversified Chemicals

Market Closed - Nyse Other stock markets 16:00:02 2025-06-23 EDT			5-day change	1st Jan Change
10.51 ^USD	+2.24%		-3.58%	-41.71%

05-28	Huntsman Corporation Announces to Close Its Maleic Anhydride Facility Located in Moers, Germany	CI
05-28	Huntsman Corporation Provides Impairment Charge Guidance for the Second Quarter of 2025	CI

9d898d9402fc47e18f724.NFDhFhQKWT7304RiaPjdcJFxpkT2HAWNnWwE62rydTA.QzOZRHFAaGaEqu5QO8vwJNg7zyKQd2i-0F1jrTuBR2phOLF6XHI1RsWL7w

Published financial data: HUNTSMAN CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	6.02B	8.45B	8.02B	6.11B	6.04B
Total Revenues	6.02B	8.45B	8.02B	6.11B	6.04B
Cost of Goods Sold, Total	4.92B	6.68B	6.48B	5.2B	5.17B
Gross Profit	1.1B	1.78B	1.55B	906M	866M
Selling General & Admin Expenses, Total	781M	827M	669M	694M	672M
R&D Expenses	129M	144M	119M	108M	114M
Other Operating Expenses	-62M	-26M	-30M	-	-2M
Other Operating Expenses, Total	848M	945M	758M	802M	784M
Operating Income	252M	830M	788M	104M	82M
Interest Expense, Total	-86M	-67M	-62M	-65M	-79M
Net Interest Expenses	-86M	-67M	-62M	-65M	-79M
Income (Loss) On Equity Invest.	42M	143M	67M	83M	44M
Currency Exchange Gains (Loss)	2M	9M	18M	-	-3M
Other Non Operating Income (Expenses)	36M	2M	-13M	-	-56M
EBT, Excl. Unusual Items	246M	917M	798M	122M	-12M
Restructuring Charges	-49M	-40M	-86M	-18M	-39M
Merger & Related Restructuring Charges	-19M	-2M	-	-	-
Gain (Loss) On Sale Of Investments	-88M	-28M	-12M	-5M	-
Gain (Loss) On Sale Of Assets	247M	28M	-	-	-39M
Other Unusual Items	-	438M	-3M	-	51M
EBT, Incl. Unusual Items	337M	1.31B	697M	99M	-39M
Income Tax Expense	46M	209M	186M	64M	61M
Earnings From Continuing Operations	291M	1.1B	511M	35M	-100M
Earnings Of Discontinued Operations	775M	-	12M	118M	-27M
Net Income to Company	1.07B	1.1B	523M	153M	-127M
Minority Interest	-32M	-59M	-63M	-52M	-62M
Net Income - (IS)	1.03B	1.04B	460M	101M	-189M
Net Income to Common Incl Extra Items	1.03B	1.04B	460M	101M	-189M
Net Income to Common Excl. Extra Items	259M	1.04B	448M	-17M	-162M
Per Share Items
Net EPS - Basic	4.69	4.77	2.29	0.57	-1.1
Basic EPS - Continuing Operations	1.17	4.77	2.23	-0.1	-0.94
Basic Weighted Average Shares Outstanding	221M	219M	201M	177M	172M
Net EPS - Diluted	4.66	4.72	2.27	0.57	-1.1
Diluted EPS - Continuing Operations	1.17	4.72	2.21	-0.1	-0.94
Diluted Weighted Average Shares Outstanding	222M	221M	203M	177M	172M
Normalized Basic EPS	0.55	2.35	2.17	0.14	-0.4
Normalized Diluted EPS	0.55	2.32	2.15	0.14	-0.4
Dividend Per Share	0.65	0.72	0.85	0.95	1
Payout Ratio	13.93	15.22	37.17	167.33	-92.06
Supplemental Items
EBITDA	520M	1.11B	1.06B	373M	363M
EBITA	285M	870M	828M	144M	122M
EBIT	252M	830M	788M	104M	82M
EBITDAR	586M	1.18B	1.11B	442M	441M
Total Revenues (As Reported)	6.02B	8.45B	8.02B	6.11B	6.04B
Effective Tax Rate - (Ratio)	13.65	15.92	26.69	64.65	-156.41
Current Domestic Taxes	-216M	119M	6M	8M	1M
Current Foreign Taxes	90M	127M	91M	66M	75M
Total Current Taxes	-126M	246M	97M	74M	76M
Deferred Domestic Taxes	167M	-70M	57M	-35M	-38M
Deferred Foreign Taxes	5M	33M	32M	25M	23M
Total Deferred Taxes	172M	-37M	89M	-10M	-15M
Normalized Net Income	122M	514M	436M	24.25M	-69.5M
Interest Capitalized	7M	11M	7M	6M	7M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	-37M	-32M	-47M	0	-2M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	135M	150M	125M	115M	121M
Net Rental Expense, Total	66M	72M	44M	69M	78M
Imputed Operating Lease Interest Expense	18.19M	19.73M	11.94M	18.7M	24.93M
Imputed Operating Lease Depreciation	47.81M	52.27M	32.06M	50.3M	53.07M
Stock-Based Comp., Other (Total)	27M	32M	29M	28M	30M
Total Stock-Based Compensation	27M	32M	29M	28M	30M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.59B	1.04B	654M	540M	340M
Total Cash And Short Term Investments	1.59B	1.04B	654M	540M	340M
Accounts Receivable, Total	910M	1.19B	834M	753M	725M
Total Receivables	910M	1.19B	834M	753M	725M
Inventory	848M	1.2B	995M	867M	917M
Prepaid Expenses	-	-	-	-	114M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	217M	500M	662M	154M	29M
Total Current Assets	3.57B	3.93B	3.14B	2.31B	2.12B
Gross Property Plant And Equipment	6.48B	6.71B	6.4B	6.65B	6.8B
Accumulated Depreciation	-3.53B	-3.73B	-3.65B	-3.91B	-3.93B
Net Property Plant And Equipment	2.95B	2.98B	2.75B	2.74B	2.88B
Long-term Investments	405M	470M	425M	438M	346M
Goodwill	533M	650M	641M	644M	633M
Other Intangibles, Total	453M	469M	425M	387M	344M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	288M	206M	147M	112M	69M
Deferred Charges Long-Term	250M	-	-	-	-
Other Long-Term Assets, Total	266M	690M	686M	611M	722M
Total Assets	8.71B	9.39B	8.22B	7.25B	7.11B
Liabilities
Accounts Payable, Total	876M	1.21B	961M	719M	770M
Accrued Expenses, Total	385M	645M	289M	302M	315M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	593M	12M	66M	12M	325M
Current Portion of Leases	52M	51M	51M	46M	54M
Current Income Taxes Payable	73M	135M	68M	67M	78M
Other Current Liabilities	-	-	266M	26M	23M
Total Current Liabilities	1.98B	2.05B	1.7B	1.17B	1.56B
Long-Term Debt	1.53B	1.54B	1.67B	1.68B	1.51B
Long-Term Leases	411M	370M	336M	334M	348M
Pension & Other Post Retirement Benefits	783M	541M	263M	256M	254M
Deferred Tax Liability Non Current	212M	161M	250M	243M	204M
Other Non Current Liabilities	127M	172M	159M	89M	70M
Total Liabilities	5.04B	4.83B	4.38B	3.77B	3.95B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	4.05B	4.1B	4.16B	4.2B	4.23B
Retained Earnings	1.56B	2.44B	2.7B	2.62B	2.24B
Treasury Stock	-731M	-934M	-1.94B	-2.29B	-2.29B
Comprehensive Income and Other	-1.36B	-1.23B	-1.3B	-1.29B	-1.23B
Total Common Equity	3.52B	4.38B	3.62B	3.25B	2.96B
Minority Interest	154M	181M	216M	227M	204M
Total Equity	3.67B	4.56B	3.84B	3.48B	3.16B
Total Liabilities And Equity	8.71B	9.39B	8.22B	7.25B	7.11B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	221M	214M	184M	172M	173M
ECS Total Common Shares Outstanding	220M	214M	184M	172M	172M
Book Value / Share	15.99	20.44	19.73	18.95	17.19
Tangible Book Value	2.53B	3.26B	2.56B	2.22B	1.98B
Tangible Book Value Per Share	11.51	15.22	13.93	12.94	11.51
Total Debt	2.58B	1.97B	2.12B	2.07B	2.24B
Net Debt	991M	930M	1.47B	1.53B	1.9B
Debt Equivalent of Unfunded Proj. Benefit Obligation	671M	308M	-3M	77M	-46M
Debt Equivalent Oper. Leases	528M	576M	352M	552M	624M
Minority Interest, Total (Incl. Fin. Div)	154M	181M	216M	227M	204M
Equity Method Investments, Total	373M	470M	425M	438M	346M
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-27M	-42M	-44M	-36M	-42M
Inventories - Raw Materials, Total	180M	282M	241M	191M	193M
Inventories - Work In Process, Total	44M	52M	40M	39M	39M
Inventories - Finished Goods, Total	651M	909M	758M	673M	727M
Land - (BS)	97M	99M	94M	99M	94M
Buildings, Total	540M	628M	570M	586M	599M
Machinery, Total	5.04B	5.12B	5.09B	5.24B	5.39B
Full Time Employees	9K	9K	7K	6K	6.3K
Accumulated Allowance for Doubtful Accounts (Supple)	26M	25M	14M	13M	8M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.03B	1.04B	460M	101M	-189M
Depreciation & Amortization - CF	235M	242M	235M	229M	241M
Amortization of Goodwill and Intangible Assets - (CF)	33M	40M	40M	40M	40M
Depreciation & Amortization, Total	268M	282M	275M	269M	281M
Amortization of Deferred Charges, Total - (CF)	8M	-	-	-	71M
(Gain) Loss From Sale Of Asset	-281M	-28M	-	-	39M
(Gain) Loss on Sale of Investments - (CF)	88M	28M	12M	5M	-
Asset Writedown & Restructuring Costs	14M	33M	12M	20M	18M
(Income) Loss On Equity Investments - (CF)	-23M	-86M	4M	-24M	57M
Stock-Based Compensation (CF)	27M	32M	29M	28M	30M
Provision and Write-off of Bad Debts	-	-	-	-	-
Net Cash From Discontinued Operations	-24M	-1M	22M	-42M	-22M
Other Operating Activities, Total	-500M	108M	164M	11M	108M
Change In Accounts Receivable	100M	-315M	146M	103M	7M
Change In Inventories	145M	-367M	-6M	125M	-77M
Change In Accounts Payable	32M	342M	-84M	-224M	69M
Change In Income Taxes	-231M	-	-	-	-
Change in Other Net Operating Assets	-404M	-121M	-120M	-163M	-129M
Cash from Operations	253M	952M	914M	209M	263M
Capital Expenditure	-249M	-342M	-272M	-230M	-184M
Sale of Property, Plant, and Equipment	75M	-	-	-	11M
Cash Acquisitions	-650M	-245M	-	-	-
Divestitures	2.28B	43M	-	544M	16M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	7M	20M	-7M	-9M	31M
Cash from Investing	1.46B	-524M	-279M	305M	-126M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	447M	219M	-	349M
Total Debt Issued	-	447M	219M	-	349M
Short Term Debt Repaid, Total	-109M	-	-	-	-
Long-Term Debt Repaid, Total	-256M	-998M	-12M	-62M	-400M
Total Debt Repaid	-365M	-998M	-12M	-62M	-400M
Issuance of Common Stock	3M	10M	6M	5M	-
Repurchase of Common Stock	-104M	-207M	-1.02B	-359M	-9M
Common Dividends Paid	-144M	-159M	-171M	-169M	-174M
Common & Preferred Stock Dividends Paid	-144M	-159M	-171M	-169M	-174M
Other Financing Activities, Total	-45M	-70M	-17M	-35M	-92M
Cash from Financing	-655M	-977M	-994M	-620M	-326M
Foreign Exchange Rate Adjustments	7M	-3M	-28M	-8M	-11M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	1.07B	-552M	-387M	-114M	-200M
Supplemental Items
Cash Interest Paid	90M	82M	66M	68M	77M
Cash Income Tax Paid (Refund)	316M	106M	194M	97M	90M
Levered Free Cash Flow	993M	191M	476M	338M	261M
Unlevered Free Cash Flow	1.05B	233M	514M	379M	310M
Change In Net Working Capital	-835M	258M	10M	-247M	-61M
Net Debt Issued / Repaid	-365M	-551M	207M	-62M	-51M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	1.85	5.73	5.59	0.84	0.71
Return on Total Capital	2.65	8.11	7.9	1.13	0.94
Return On Equity %	8.96	26.82	12.17	0.96	-3.01
Return on Common Equity	8.35	26.47	11.2	-0.49	-5.22
Margin Analysis
Gross Profit Margin %	18.28	21	19.27	14.83	14.35
SG&A Margin	12.98	9.78	8.34	11.36	11.13
EBITDA Margin %	8.64	13.16	13.25	6.1	6.01
EBITA Margin %	4.74	10.29	10.32	2.36	2.02
EBIT Margin %	4.19	9.82	9.82	1.7	1.36
Income From Continuing Operations Margin %	4.84	13.06	6.37	0.57	-1.66
Net Income Margin %	17.18	12.36	5.73	1.65	-3.13
Net Avail. For Common Margin %	4.3	12.36	5.58	-0.28	-2.68
Normalized Net Income Margin	2.02	6.08	5.43	0.4	-1.15
Levered Free Cash Flow Margin	16.5	2.26	5.93	5.54	4.32
Unlevered Free Cash Flow Margin	17.39	2.75	6.41	6.2	5.14
Asset Turnover
Asset Turnover	0.71	0.93	0.91	0.79	0.84
Fixed Assets Turnover	2.1	2.85	2.88	2.23	2.15
Receivables Turnover (Average Receivables)	6.46	8.07	8.68	7.7	8.17
Inventory Turnover (Average Inventory)	5.58	6.52	6.37	5.59	5.8
Short Term Liquidity
Current Ratio	1.8	1.92	1.85	1.97	1.36
Quick Ratio	1.26	1.09	0.87	1.1	0.68
Operating Cash Flow to Current Liabilities	0.13	0.46	0.54	0.18	0.17
Days Sales Outstanding (Average Receivables)	56.65	45.25	42.06	47.39	44.81
Days Outstanding Inventory (Average Inventory)	65.56	56	57.28	65.29	63.15
Average Days Payable Outstanding	64.04	54.09	58.86	60.39	52.2
Cash Conversion Cycle (Average Days)	58.17	47.16	40.49	52.29	55.76
Long Term Solvency
Total Debt/Equity	70.35	43.23	55.31	59.46	70.72
Total Debt / Total Capital	41.3	30.18	35.61	37.29	41.43
LT Debt/Equity	52.79	41.85	52.27	57.79	58.74
Long-Term Debt / Total Capital	30.99	29.22	33.65	36.24	34.41
Total Liabilities / Total Assets	57.84	51.46	53.28	52.01	55.54
EBIT / Interest Expense	2.93	12.39	12.71	1.6	1.04
EBITDA / Interest Expense	6.81	17.67	17.85	6.8	5.58
(EBITDA - Capex) / Interest Expense	3.92	12.57	13.47	3.26	3.25
Total Debt / EBITDA	4.41	1.66	1.92	4.68	5.07
Net Debt / EBITDA	1.69	0.79	1.33	3.46	4.3
Total Debt / (EBITDA - Capex)	7.67	2.34	2.54	9.75	8.7
Net Debt / (EBITDA - Capex)	2.94	1.1	1.76	7.21	7.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.46	40.46	4.6	-23.83	-1.23
Gross Profit, 1 Yr. Growth %	-20.41	61.36	-2.4	-41.4	-4.42
EBITDA, 1 Yr. Growth %	-25.39	100.36	3.2	-64.91	-2.68
EBITA, 1 Yr. Growth %	-36.95	171.88	2.73	-82.61	-15.28
EBIT, 1 Yr. Growth %	-42.2	189.2	2.87	-86.8	-21.15
Earnings From Cont. Operations, 1 Yr. Growth %	-32.17	279.38	-51.56	-93.15	-385.71
Net Income, 1 Yr. Growth %	83.99	1.06	-55.98	-78.04	-287.13
Normalized Net Income, 1 Yr. Growth %	-41.57	322.28	-7.73	-94.43	-428.99
Diluted EPS Before Extra, 1 Yr. Growth %	-31.18	303.42	-50.89	-104.52	841.31
Accounts Receivable, 1 Yr. Growth %	-4.51	30.33	-17.83	-9.71	-3.72
Inventory, 1 Yr. Growth %	-7.22	41.63	-4.14	-12.86	5.77
Net Property, Plant and Equip., 1 Yr. Growth %	6.15	0.98	-2.58	-0.33	4.85
Total Assets, 1 Yr. Growth %	4.72	7.79	-12.48	-11.82	-1.85
Tangible Book Value, 1 Yr. Growth %	14.41	28.66	-21.51	-13.21	-10.72
Common Equity, 1 Yr. Growth %	30.96	24.41	-17.22	-10.29	-8.98
Cash From Operations, 1 Yr. Growth %	-71.79	276.28	-3.99	-77.13	25.84
Capital Expenditures, 1 Yr. Growth %	-9.12	37.35	-16.56	-15.44	-20
Levered Free Cash Flow, 1 Yr. Growth %	-785.25	-81.19	219.56	-28.88	-22.9
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.49K	-78.21	169.72	-26.34	-18.14
Dividend Per Share, 1 Yr. Growth %	0	11.54	17.24	11.76	5.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.04	11.52	21.65	-10.74	-13.26
Gross Profit, 2 Yr. CAGR %	-21.03	13.33	25.79	-24.37	-25.16
EBITDA, 2 Yr. CAGR %	-30.09	25.24	40.96	-39.82	-41.56
EBITA, 2 Yr. CAGR %	-41.22	36.93	63.7	-57.73	-61.61
EBIT, 2 Yr. CAGR %	-44.53	36.11	68.97	-63.15	-67.74
Earnings From Cont. Operations, 2 Yr. CAGR %	-35.01	60.42	32.97	-81.79	-55.76
Net Income, 2 Yr. CAGR %	75.16	36.36	-33.3	-68.91	-35.9
Normalized Net Income, 2 Yr. CAGR %	-18.49	57.08	96.37	-77.34	-59.63
Diluted EPS Before Extra, 2 Yr. CAGR %	-13.16	66.63	38.03	-85.09	-34.74
Accounts Receivable, 2 Yr. CAGR %	-12.29	11.56	-4.27	-13.87	-6.76
Inventory, 2 Yr. CAGR %	-7.91	14.63	8.32	-8.61	-4
Net Property, Plant and Equip., 2 Yr. CAGR %	11.97	3.54	-3.43	-1.46	2.23
Total Assets, 2 Yr. CAGR %	4.67	6.25	-2.87	-12.15	-6.97
Tangible Book Value, 2 Yr. CAGR %	11.65	21.33	0.49	-17.47	-11.98
Common Equity, 2 Yr. CAGR %	18.17	27.65	1.48	-13.83	-9.64
Cash From Operations, 2 Yr. CAGR %	-54.22	3.02	90.07	-53.15	-46.36
Capital Expenditures, 2 Yr. CAGR %	-0.4	11.72	7.13	-16	-17.75
Levered Free Cash Flow, 2 Yr. CAGR %	-22.48	17.87	-31.36	50.76	-25.95
Unlevered Free Cash Flow, 2 Yr. CAGR %	-22.09	85.01	-30.45	40.96	-22.35
Dividend Per Share, 2 Yr. CAGR %	0	5.61	14.35	14.47	8.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4.2	3.59	5.68	4.07	-7.68
Gross Profit, 3 Yr. CAGR %	-12.66	0.21	3.81	-2.48	-18.23
EBITDA, 3 Yr. CAGR %	-19.8	1.48	14.45	-11.33	-29.36
EBITA, 3 Yr. CAGR %	-28.57	1.79	21.29	-22.47	-46.71
EBIT, 3 Yr. CAGR %	-31.35	0.45	20.71	-27.77	-52.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-17.11	17.02	6	-50.52	-54.41
Net Income, 3 Yr. CAGR %	17.59	45.82	-6.46	-53.95	-43.45
Normalized Net Income, 3 Yr. CAGR %	-25.12	41.04	27.88	-40.13	-47.2
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.01	44.9	9.14	-55.82	-40.64
Accounts Receivable, 3 Yr. CAGR %	-10.82	0.08	-4.35	-6.12	-10.61
Inventory, 3 Yr. CAGR %	-7.54	6.3	2.87	0.74	-4.05
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.62	8.18	-0.34	-2.41	0.6
Total Assets, 3 Yr. CAGR %	-5.25	5.7	-0.4	-5.95	-8.84
Tangible Book Value, 3 Yr. CAGR %	1.48	17.05	4.93	-4.3	-15.28
Common Equity, 3 Yr. CAGR %	10.33	20.21	10.49	-2.61	-12.24
Cash From Operations, 3 Yr. CAGR %	-40.79	-7.61	0.63	-6.17	-34.87
Capital Expenditures, 3 Yr. CAGR %	2.09	10.86	-0.24	-0.99	-17.36
Levered Free Cash Flow, 3 Yr. CAGR %	33.18	-51.29	51.29	-30.54	20.56
Unlevered Free Cash Flow, 3 Yr. CAGR %	48.88	-48.7	96.32	-29.1	17.6
Dividend Per Share, 3 Yr. CAGR %	9.14	3.71	9.35	13.48	11.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5.86	2.37	3.23	-4.28	-2.35
Gross Profit, 5 Yr. CAGR %	-8.7	3.18	-1.31	-12.48	-8.92
EBITDA, 5 Yr. CAGR %	-13.82	4.07	1.07	-18.91	-12.53
EBITA, 5 Yr. CAGR %	-18.97	6.94	1.15	-29.47	-23.45
EBIT, 5 Yr. CAGR %	-20.83	6.35	0.23	-33.82	-28.8
Earnings From Cont. Operations, 5 Yr. CAGR %	-7.43	24.78	0	-44.9	-25.27
Net Income, 5 Yr. CAGR %	61.89	26.24	-6.27	-21.42	-19.58
Normalized Net Income, 5 Yr. CAGR %	-18.72	16.93	8.48	-33.27	-19.72
Diluted EPS Before Extra, 5 Yr. CAGR %	-6.19	27.7	5.89	-42.21	-11.15
Accounts Receivable, 5 Yr. CAGR %	-8.88	0.05	-8.25	-8.64	-5.32
Inventory, 5 Yr. CAGR %	-12.9	5.52	-1.5	-2.81	0.07
Net Property, Plant and Equip., 5 Yr. CAGR %	-7.88	-0.37	-2.35	3.11	0.68
Total Assets, 5 Yr. CAGR %	-2.36	0.44	-4.31	-1.84	-3.08
Tangible Book Value, 5 Yr. CAGR %	15.36	23.75	1.08	1.79	-2.19
Common Equity, 5 Yr. CAGR %	19.53	27.74	6.7	5.23	1.95
Cash From Operations, 5 Yr. CAGR %	-15.14	-2.64	-5.6	-29.58	-21.76
Capital Expenditures, 5 Yr. CAGR %	-11.59	1.47	3.06	-1.73	-7.66
Levered Free Cash Flow, 5 Yr. CAGR %	13.45	-22.31	2.51	-27.18	13.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.78	-21.9	10.16	-26.14	35.47
Dividend Per Share, 5 Yr. CAGR %	5.39	7.71	11.2	7.89	9